CG Oncology CGON Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities at other companies

JBT Marel CorporationJBTM

$403M-13.9%

CG OncologyCGON

$307K—

D-Wave QuantumQBTS

$28.37M—

Brown & BrownBRO

$12M—

Keysight TechnologiesKEYS

$168M—

Mirion TechnologiesMIR

$32.9M—

FAQ

What is CG Oncology's business combination, recognized identifiable assets acquired and liabilities assumed, deferred tax liabilities?

CG Oncology (CGON) reported business combination, recognized identifiable assets acquired and liabilities assumed, deferred tax liabilities of $307K in Q2 2026.

What does business combination, recognized identifiable assets acquired and liabilities assumed, deferred tax liabilities mean?

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities as reported by CG Oncology, Inc. Common stock.